GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rafarma Pharmaceuticals Inc (OTCPK:RAFA) » Definitions » 3-Year Revenue Growth Rate

Rafarma Pharmaceuticals (Rafarma Pharmaceuticals) 3-Year Revenue Growth Rate : 0.00% (As of . 20)


View and export this data going back to . Start your Free Trial

What is Rafarma Pharmaceuticals 3-Year Revenue Growth Rate?

Rafarma Pharmaceuticals's Revenue per Share for the three months ended in . 20 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Competitive Comparison of Rafarma Pharmaceuticals's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Rafarma Pharmaceuticals's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rafarma Pharmaceuticals's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rafarma Pharmaceuticals's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Rafarma Pharmaceuticals's 3-Year Revenue Growth Rate falls into.



Rafarma Pharmaceuticals 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Rafarma Pharmaceuticals  (OTCPK:RAFA) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Rafarma Pharmaceuticals 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Rafarma Pharmaceuticals's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Rafarma Pharmaceuticals (Rafarma Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
12465 Sourth Fort Street, Draper, UT, USA, 84020
Rafarma Pharmaceuticals Inc manufactures and distributes colloidal systems, fine chemistry, pharmaceutical substances, pharmaceutical development, new drugs, pharmaceutical packaging, and other technologies in the field of biotechnology in Europe and Asia.

Rafarma Pharmaceuticals (Rafarma Pharmaceuticals) Headlines

From GuruFocus

RAFA To Add Major Component to the Tashkent Pharma Park

By GuruFocusNews GuruFocusNews 12-17-2021

Rafarma Closes Biocogency Merger

By Marketwired Marketwired 10-19-2020

Rafarma Pharmaceuticals strengthens its position in Central Asia

By GuruFocusNews GuruFocusNews 04-29-2022

Rafarma Embarks on Aggressive Global Partnerships Plan

By Marketwired Marketwired 03-04-2021

Rafarma's Global Pharmaceutical Strategy At A Glance

By Marketwired Marketwired 05-18-2021

Explosive Growth Launches Kraspharma Into REMEDIUM TOP-5

By GuruFocusNews GuruFocusNews 11-19-2021